Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

saudi dox for pharmaceutical industries, saudi arabia - colecalciferol - capsule, soft - 50000 iu

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

saudi dox for pharmaceutical industries, saudi arabia - colecalciferol - capsule, soft - 50000 iu

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

jamjoom pharmaceuticals company, saudi arabia - colecalciferol - capsule, soft - 50000 iu

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

dar aldawa, jordan - colecalciferol - capsule - 50000 iu

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abiogen pharma s.p.a., italy - colecalciferol - solution - 100000 iu/ml

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride, quantity: 25 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; colloidal anhydrous silica; magnesium stearate; sodium starch glycollate; disodium edetate; purified talc - this product accepted for registration as 'currently supplied' at the time of commencement of the act. variation to pregnancy statement in product information were approved as specified in the letter of 13 august 1992 from dr bijoy varma. indicated for the treatment of drug resistant, moderate to severe, hypertension. this drug is not a first line antihypertensive drug and is better used in combination with other therapy such as a sympatholytic agent and a diuretic. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

Italia - italiană - myHealthbox

mylan - paracalcitolo - soluzione iniettabile - 2 microgrammi/ml - agenti antiparatiroidei - paracalcitolo è indicato per la prevenzione ed il trattamento dell’iperparatiroidismo secondario nei pazienti affetti da insufficienza renale cronica sottoposti ad emodialisi.

Italia - italiană - myHealthbox

mylan - paracalcitolo - soluzione iniettabile - 5 microgrammi/ml - agenti antiparatiroidei - paracalcitolo è indicato per la prevenzione ed il trattamento dell’iperparatiroidismo secondario nei pazienti affetti da insufficienza renale cronica sottoposti ad emodialisi.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydralazine hydrochloride, quantity: 50 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; sodium starch glycollate; colloidal anhydrous silica; purified talc; disodium edetate; magnesium stearate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; iron oxide yellow; macrogol 4000; erythrosine - this product accepted for registration as 'currently supplied' at the time of commencement of the act. amended product information (variation to pregnancy statement) was approved as specified in the letter of 13 august 92 from dr bijoy varma. indications as at 28 november 2001 : hypertension (drug resistant, moderate to severe): as supplementary medication for use together with other antihypertensives such as "beta"-blockers and diuretics; the complementary mechanisms of action of such combined therapy enable the drugs to exert their antihypertensive effects at low doses; in addition, unwanted accompanying effects of the individual substances are either partially offset or even cancelled out.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amoxicillin trihydrate -